Brief: Athira Pharma Provides 2024 Clinical Pipeline Outlook And Business Update
08/01/2024 13:26
Jan 8 (Reuters) - Athira Pharma Inc ATHA.O :
* ATHIRA PHARMA PROVIDES 2024 CLINICAL PIPELINE OUTLOOK AND
BUSINESS UPDATE
* ATHIRA PHARMA INC - PLANS TO INITIATE FIRST-IN-HUMAN
STUDIES OF
ATH-1105 TO TREAT AMYOTROPHIC LATERAL SCLEROSIS IN FIRST HALF OF
2024
Source text for Eikon: ID:nGNXbk3xVC
Further company coverage: ATHA.O
((Reuters.Briefs@thomsonreuters.com;))